FR2414507A1 - Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone - Google Patents
Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamoneInfo
- Publication number
- FR2414507A1 FR2414507A1 FR7800969A FR7800969A FR2414507A1 FR 2414507 A1 FR2414507 A1 FR 2414507A1 FR 7800969 A FR7800969 A FR 7800969A FR 7800969 A FR7800969 A FR 7800969A FR 2414507 A1 FR2414507 A1 FR 2414507A1
- Authority
- FR
- France
- Prior art keywords
- eburnamonine
- epi
- insufficiency
- trans
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Trans-eburnamonine or 21-epi-eburnamonine of formula (I) and its acid addition salts are new. Used in treatment of cerebral oxygeneration insufficiency by oral administration of unit doses of 10-30 mg (I) to give a daily dose of 10-100mg.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7800969A FR2414507A1 (en) | 1978-01-13 | 1978-01-13 | Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone |
BE192811A BE873373A (en) | 1978-01-13 | 1979-01-10 | TRANS-EBURNAMONINE |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7800969A FR2414507A1 (en) | 1978-01-13 | 1978-01-13 | Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2414507A1 true FR2414507A1 (en) | 1979-08-10 |
Family
ID=9203441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7800969A Pending FR2414507A1 (en) | 1978-01-13 | 1978-01-13 | Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE873373A (en) |
FR (1) | FR2414507A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529553A1 (en) * | 1982-06-30 | 1984-01-06 | Richter Gedeon Vegyeszet | EBURNANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1978
- 1978-01-13 FR FR7800969A patent/FR2414507A1/en active Pending
-
1979
- 1979-01-10 BE BE192811A patent/BE873373A/en unknown
Non-Patent Citations (1)
Title |
---|
NV6013/65 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2529553A1 (en) * | 1982-06-30 | 1984-01-06 | Richter Gedeon Vegyeszet | EBURNANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Also Published As
Publication number | Publication date |
---|---|
BE873373A (en) | 1979-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI920956A0 (en) | DOSERINGSFORM FOER ADMINISTRERING AV ORAL HYPOGLYKEMISK GLIPISID. | |
IE790951L (en) | Carnitine solution | |
GB8326878D0 (en) | Administering medicaments to patients | |
GB8602264D0 (en) | Administering medicaments to patients | |
EP0465508A4 (en) | Dietary supplement for insulin-resistant diabetics | |
ZA763707B (en) | A device for administering an anaesthetic to a patient | |
PT66789B (en) | Process for the preparation of pharmaceutical compositionshaving high rate of resorption from heart glicosides for itself hardly resorptive to be parenterically administered | |
ES8705371A1 (en) | Aminopropanol derivatives, process for their preparation, their use and medicines containing them. | |
ES472847A1 (en) | 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine. | |
KR910005858A (en) | Fatty acid therapy | |
DE3478749D1 (en) | Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism | |
EP0388799A3 (en) | Use of human interferon-beta for stimulation of erythropoieses | |
FR2414507A1 (en) | Trans or 21-epi-eburnamonine - for treatment of cerebral oxygenation insufficiency has superior therapeutic index to vincamine and vincamone | |
ZA936300B (en) | Use of L-carnitine and acyl L-carnitines for treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients | |
FR2155927A1 (en) | 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity | |
ES8205190A1 (en) | 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid | |
MY100483A (en) | Niflumic acid morpholinoethyl ester diniflumate, preparation, use in therapeutics as analgesic and anti- inflammatory | |
ES8400731A1 (en) | Derivatives of 3-phenoxy-3-propanol, their preparation and their therapeutic use. | |
PT78608A (en) | Process for preparing a composition to promote the absorption of medicaments administered via rectum | |
MY101916A (en) | Etoposide oral dosage form. | |
DE3369327D1 (en) | Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation | |
EP0212310A3 (en) | Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia | |
FR2447368A1 (en) | PHENYLETHYLAMINE DERIVATIVES, THEIR PREPARATION AND MEDICAMENT CONTAINING THESE SUBSTANCES | |
SU1168252A1 (en) | Method of treatment of patients ill with psoriasis | |
FR2201898A1 (en) | Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders |